Well it has finally happened. It looks like the Abbott buyout will be going down sometime in the second quarter of 2010. The rumor is that 40% of the force will be let go and the remaining population will be moved to the Abbott division in Alameda, CA . The really big thing is most employees at the big "A" @ Alameda, CA are aware. More to come stay tuned
California
Spectrum and Topotarget
Submitted by Anonymous on Tue, 02/02/2010 - 11:28- The Rumor Mill
- Biotechnology
- biotechnology
- California
- cancer
- Company Technology
- Company Ticker
- Conference Call
- FDA
- Irvine
- National Cancer Institute
- paclitaxel
- Peripheral T-Cell Lymphoma
- Person Career
- Quotation
- Spectrum Pharmaceuticals
- TopoTarget A/S
- TopoTarget Will Jointly Fund
- tumors
- U.S. Food and Drug Administration
Spectrum buying into cancer drug which is potential blockbuster. Not cheap, but probably worth it...
Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trial
•Belinostat, a HDAC Inhibitor, is Currently in a Multicenter, Registrational Trial Under a Special Protocol Assessment for Peripheral T-Cell Lymphoma (PTCL)
Conference on 6th Annual Biosimilars (Workshop Only)
Submitted by bharatbookseo on Thu, 14/01/2010 - 04:55- Analytical Technologies
- Bethesda
- BioInsights
- Biopharmaceuticals
- Biotechnology
- biotechnology
- Biotechnology
- Boston
- Boston Harbor Hotel
- Brian E. Harvey
- Brian J. Del Buono
- California
- Clifford S. Mintz
- CommonHealth
- Company Affiliates
- David L. Gollaher
- Deloitte LLP
- Duu-Gong Wu
- Eden Biodesign
- Europe
- Executive Officer
- FDA
- Fethi Trabelsi
- Food and Drug Administration
- Francis B. Palumbo
- Gil Bashe
- GTCR Golder Rauner
- Health Economics
- healthcare
- Healthcare Economics LLC
- James Harris
- Kristie Kuhl
- Les Jordan
- Life Sciences
- Makovsky
- Maryland
- Mateja Urlep
- Microsoft
- Paraxel Consulting
- Person Career
- Person Education
- Pfizer
- pharmaceutical
- Pharmanet
- Process Control
- Regulatory Policy
- Roger Lias
- Rowes Wharf
- Scientific
- Sterne
- Terry Hisey
- TikhePharma
- Tina S. Morris
- United States
- University of Maryland
- USD
- Vice Chairman
- WPP Group
http://www.bharatbook.com/detail.asp?id=114527&rt=Conference-on-6th-Annu...
6TH ANNUAL BIOSIMILARS CONFERENCE
Revolutionizing biosimilars market - debates, challenges and innovations
2nd - 4th March 2010, Boston Harbor Hotel at Rowes Wharf, Boston, USA
Background Info
Key Speakers
Conference on 6th Annual Biosimilars (Conference Only)
Submitted by bharatbookseo on Thu, 14/01/2010 - 04:52- Analytical Technologies
- Bethesda
- BioInsights
- Biopharmaceuticals
- Biotechnology
- biotechnology
- Biotechnology
- Boston
- Boston Harbor Hotel
- Brian E. Harvey
- Brian J. Del Buono
- California
- Clifford S. Mintz
- CommonHealth
- Company Affiliates
- David L. Gollaher
- Deloitte LLP
- Duu-Gong Wu
- Eden Biodesign
- Europe
- Executive Officer
- FDA
- Fethi Trabelsi
- Food and Drug Administration
- Francis B. Palumbo
- Gil Bashe
- GTCR Golder Rauner
- Health Economics
- healthcare
- Healthcare Economics LLC
- James Harris
- Kristie Kuhl
- Les Jordan
- Life Sciences
- Makovsky
- Maryland
- Mateja Urlep
- Microsoft
- Paraxel Consulting
- Person Career
- Person Education
- Pfizer
- pharmaceutical
- Pharmanet
- Process Control
- Regulatory Policy
- Roger Lias
- Rowes Wharf
- Scientific
- Sterne
- Terry Hisey
- TikhePharma
- Tina S. Morris
- United States
- University of Maryland
- USD
- Vice Chairman
- WPP Group
http://www.bharatbook.com/detail.asp?id=114526&rt=Conference-on-6th-Annu...
6TH ANNUAL BIOSIMILARS CONFERENCE
Revolutionizing biosimilars market - debates, challenges and innovations
2nd - 4th March 2010, Boston Harbor Hotel at Rowes Wharf, Boston, USA
Background Info
Key Speakers
Conference on 6th Annual Biosimilars (Conference and WorkShop)
Submitted by bharatbookseo on Thu, 14/01/2010 - 04:50- Analytical Technologies
- Bethesda
- BioInsights
- Biopharmaceuticals
- Biotechnology
- biotechnology
- Biotechnology
- Boston
- Boston Harbor Hotel
- Brian E. Harvey
- Brian J. Del Buono
- California
- Clifford S. Mintz
- CommonHealth
- Company Affiliates
- David L. Gollaher
- Deloitte LLP
- dietary supplements
- Duu-Gong Wu
- Eden Biodesign
- Europe
- Executive Officer
- FDA
- Fethi Trabelsi
- Food and Drug Administration
- Francis B. Palumbo
- Gil Bashe
- GTCR Golder Rauner
- Health Economics
- healthcare
- Healthcare Economics LLC
- James Harris
- Kristie Kuhl
- Les Jordan
- Life Sciences
- Makovsky
- Maryland
- Mateja Urlep
- Microsoft
- Paraxel Consulting
- Person Career
- Person Education
- Pfizer
- pharmaceutical
- Pharmanet
- Process Control
- Regulatory Policy
- Roger Lias
- Rowes Wharf
- Scientific
- Sterne
- Terry Hisey
- TikhePharma
- Tina S. Morris
- United States
- United States Senate
- University of Maryland
- USD
- Vice Chairman
- WPP Group
http://www.bharatbook.com/detail.asp?id=114525&rt=Conference-on-6th-Annu...
6TH ANNUAL BIOSIMILARS CONFERENCE
Revolutionizing biosimilars market - debates, challenges and innovations
2nd - 4th March 2010, Boston Harbor Hotel at Rowes Wharf, Boston, USA
Background Info
Key Speakers
Sued by Life Tech, Biosearch Denies Infringing PCR Probe IP, Claims Patents are Invalid
Submitted by Anonymous on Wed, 13/01/2010 - 00:44From GenomeWeb
Biosearch Technologies, sued last September by Life Technologies and its Applied Biosystems business for allegedly infringing five patents related to PCR probes, last week denied the charges and said the patents are invalid.
Conference on 6th Annual Biosimilars (Conference and WorkShop)
Submitted by bharatbookseo on Sat, 09/01/2010 - 06:30- Analytical Technologies
- Bethesda
- BioInsights
- Biopharmaceuticals
- Biotechnology
- biotechnology
- Biotechnology
- Boston
- Boston Harbor Hotel
- Brian E. Harvey
- Brian J. Del Buono
- California
- Clifford S. Mintz
- CommonHealth
- Company Affiliates
- David L. Gollaher
- Deloitte LLP
- Duu-Gong Wu
- Eden Biodesign
- Europe
- Executive Officer
- FDA
- Fethi Trabelsi
- Food and Drug Administration
- Francis B. Palumbo
- Gil Bashe
- GTCR Golder Rauner
- Health Economics
- healthcare
- Healthcare Economics LLC
- James Harris
- Kristie Kuhl
- Les Jordan
- Life Sciences
- Makovsky
- Maryland
- Mateja Urlep
- Microsoft
- Paraxel Consulting
- Person Career
- Person Education
- Pfizer
- pharmaceutical
- Pharmanet
- Process Control
- Regulatory Policy
- Roger Lias
- Rowes Wharf
- Scientific
- Sterne
- Terry Hisey
- TikhePharma
- Tina S. Morris
- United States
- University of Maryland
- USD
- Vice Chairman
- WPP Group
6TH ANNUAL BIOSIMILARS CONFERENCE
Revolutionizing biosimilars market - debates, challenges and innovations
2nd - 4th March 2010, Boston Harbor Hotel at Rowes Wharf, Boston, USA
Background Info
Key Speakers
• Tina S. Morris, Vice President, Biologics and Biotechnology, United States Pharmacopeial Convention
• Yining Zhao, Associate Research Fellow, Strategy Management Group, Pfizer
Sr. HR Specialist at Beckman Coulter in Brea, CA
Submitted by Anonymous on Tue, 17/11/2009 - 03:07Wonder what the REAL story is behind this? There is a posting on Indeed.com for a Sr. HR Specialist at Beckman Coulter in Brea, CA.
One interesting requirement in the job description:
MUST BE ABLE TO RELOCATE TO ANY BECKMAN COULTER FACILITY OUTSIDE OF THE ORANGE COUNTY AREA.
Apparently SG needs a new hatchet man.
Biosearch Technologies Licenses H1N1 Flu IP from CDC
Submitted by Anonymous on Wed, 04/11/2009 - 14:46November 04, 2009
By a GenomeWeb staff reporter
Feed NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed H1N1 influenza signatures and the influenza A sub-typing panel signatures from the US Centers for Disease Control and Prevention.
Nanosafety in Uncertain Times
Submitted by ianano on Fri, 09/10/2009 - 15:26October 21, 2009
5:00 p.m. - 7:00 p.m.
1290 Parkmoor Ave
San José, CA 95125
This event focuses on California's passage of AB-289 and what this means for California organizations involved in the sale, manufacture, importing or exporting of carbon nanotubes. Organizations are invited to freely express their perspective on this legislation.
